In this case report, we demonstrate a patient with ICD lead endocarditis and Serratia marcescens grow out on blood cultures.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Permenant pacemaker-implantable cardioverter-defibrillator (ICD) lead endocarditis is a rare and mortal pacemaker infection.
📊
Key Findings & Data:Permenant pacemaker-implantable cardioverter-defibrillator (ICD) lead endocarditis is a rare and mortal pacemaker infection.
💡
Conclusion & Impact:In this case report, we demonstrate a patient with ICD lead endocarditis and Serratia marcescens grow out on blood cultures.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Permenant pacemaker-implantable cardioverter-defibrillator (ICD) lead endocarditis is a rare and mortal pacemaker infection. In this case report, we demonstrate a patient with ICD lead endocarditis and Serratia marcescens grow out on blood cultures.
Özet
Kalıcı pacemaker- implante kardiyoverter-defibrilatör (ICD) lead endokarditi nadir görülen ve ölümcül bir pacemaker enfeksiyonudur. Bu olgu bildiriminde ICD lead endokarditi gelişen ve kan kültürlerinde Serratia marcescens üreyen hasta sunulacaktır.
🔖
Cite This Article
ÇETİN, M., BALUN, A., KIZILTUNÇ, E., ŞAHİN, M., ÇİÇEKÇİOĞLU, H., GÜVEN, Z. Ç., ÖRNEK, E., GÖK, M., KUNDİ, H., ULUSOY, F. V. (2014). Implantable cardioverter-defibrillator lead endocarditis induced by serratia marcescens. MN Kardiyoloji, Cilt: 21 - Sayı: 4, 235–337. https://ajindex.com/articles/297294
Cabell CH, Heidenreich PA, Chu VH, et al. Increasing rates of cardiac device infections among Medicare beneficiar- ies: 1990-1999. Am Heart J 2004;147:582-6 2. Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007;49:1851-9. 3. De Silva K, Fife A, Murgatroyd F, Gall N. Pacemaker endo- carditis: an important clinical entity. BMJ Case Rep (Epub 2009 Nov 18). 4. Hejazi A, Falkiner FR. Serratia marcescens. J Med Micro- biol 1997;46:903-12. 5. Cooper R, Mills J. Serratia endocarditis. A follow-up re- port. Arch Intern Med 1980;140:199-202. 6. Morpeth S, Murdoch D, Cabell CH, et al. International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investi gators. Non-HACEK gram-negative bacil- lus endocarditis. Ann Intern Med 2007;147: 829-35. 7. Gandelman G, Frishman WH, Wiese C, et al Intravascular device infections: epidemiology, diagnosis and manage- ment. Cardiol Rev 2007;15:13-23. 8. Karchmer AW, Longworth DL. Infections of intracardiac devices. Cardiol Clin 2003;21:253-71. 9. Greenspon AJ, Prutkin JM, Sohail MR. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). J Am Coll Cardiol 2012;59:681-7. 10. Victor F, De Place C, Camus C, et al. Pacemaker lead in- fection: echocardiographic features, management, and outcome. Heart 1999;81:82-7. 11. Cacoub P, Leprince P, Nataf P, et al. Pacemaker infective endocarditis. Am J Cardiol 1998;82:480-4. 12. Rallidis LS, Komminos KA, Dapasteriadis EG. Pacemaker- related endocarditis: the value of transoesophageal echocardiography in diagnosis and treatment. Acta Car- diol 2003;58:31-4.